GSK and Tempus Forge Ahead: A Pioneering Collaboration in Precision Medicine to Propel R&D
In a significant stride towards advancing precision medicine, GlaxoSmithKline (GSK) has announced a three-year collaboration agreement with Tempus, a leader in data-driven precision medicine, to get access to Tempus’ AI-enable…